ONKAIDO THERAPEUTICS Trademark

Trademark Overview

On Friday, January 24, 2014, a trademark application was filed for ONKAIDO THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the ONKAIDO THERAPEUTICS trademark a serial number of 86174542. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, March 26, 2018. This trademark is owned by Moderna Therapeutics, Inc.. The ONKAIDO THERAPEUTICS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals, medicines, biologics, biotherapeutics, biosimilars and therapeutics, namely, nucleic acid therapeutics and polypeptide therapeutics for use in oncology
onkaido therapeutics

General Information

Serial Number86174542
Word MarkONKAIDO THERAPEUTICS
Filing DateFriday, January 24, 2014
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, March 26, 2018
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 23, 2014

Trademark Statements

Goods and ServicesPharmaceuticals, medicines, biologics, biotherapeutics, biosimilars and therapeutics, namely, nucleic acid therapeutics and polypeptide therapeutics for use in oncology
NOT AVAILABLE"THERAPEUTICS"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, February 5, 2014
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameMODERNATX, INC.
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressCAMBRIDGE, MA 02141
Party NameModerna Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02141
Party NameModerna Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Trademark Events

Event DateEvent Description
Tuesday, April 29, 2014ASSIGNED TO EXAMINER
Thursday, May 8, 2014NON-FINAL ACTION WRITTEN
Tuesday, January 28, 2014NEW APPLICATION ENTERED
Wednesday, February 5, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, May 8, 2014NON-FINAL ACTION E-MAILED
Thursday, May 8, 2014NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, November 12, 2014ASSIGNED TO LIE
Tuesday, July 22, 2014UNRESPONSIVE/DUPLICATE PAPER RECEIVED
Tuesday, July 22, 2014APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, October 24, 2014TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, October 24, 2014CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, October 24, 2014TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, October 27, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 7, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, August 28, 2015SOU EXTENSION 1 GRANTED
Saturday, November 15, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, December 3, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 23, 2014PUBLISHED FOR OPPOSITION
Tuesday, December 23, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 17, 2015NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, August 14, 2015SOU TEAS EXTENSION RECEIVED
Friday, August 14, 2015SOU EXTENSION 1 FILED
Friday, August 28, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Saturday, August 29, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 4, 2016SOU EXTENSION 3 FILED
Monday, February 15, 2016SOU TEAS EXTENSION RECEIVED
Monday, February 15, 2016SOU EXTENSION 2 FILED
Sunday, March 20, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, March 24, 2016SOU EXTENSION 2 GRANTED
Friday, March 25, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 15, 2016TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, June 15, 2016ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, August 4, 2016SOU TEAS EXTENSION RECEIVED
Wednesday, February 8, 2017SOU EXTENSION 4 FILED
Friday, August 12, 2016DIVISIONAL REQUEST RECEIVED
Friday, August 12, 2016TEAS REQUEST TO DIVIDE RECEIVED
Friday, August 26, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, August 30, 2016DIVISIONAL PROCESSING COMPLETE
Tuesday, August 30, 2016SOU EXTENSION 3 GRANTED
Wednesday, August 31, 2016CORRECTED NOA E-MAILED
Wednesday, August 31, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, November 2, 2016AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, February 8, 2017SOU TEAS EXTENSION RECEIVED
Wednesday, February 8, 2017SOU EXTENSION 4 GRANTED
Friday, February 10, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 15, 2017SOU TEAS EXTENSION RECEIVED
Tuesday, August 15, 2017SOU EXTENSION 5 FILED
Thursday, August 24, 2017CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, August 31, 2017SOU EXTENSION 5 GRANTED
Friday, September 1, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 26, 2018ABANDONMENT - NO USE STATEMENT FILED
Monday, March 26, 2018ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED

Related Keywords

therapeutics onkaido nucleic acid polypeptide oncology namely pharmaceuticals biologics biotherapeutics biosimilars